BIOO SCIENTIFIC CORPORATION

Biotech · Acquired

Single-cell DNA methylation sequencing library preparation protocols and instrument

Claim this profile

Follows are private to you and power your alerts

Updated · biooscientific.com

Sector
Biotech
Total capital
$4.2M
Federal grants
$2.8M
7 awards · 2008–2016
Rank in peer group#31 of 42
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
$1.4M
15 awards · Health and Human S, Defense, Agriculture
Rank in Biotech#162 of 4373
Granted patents
14
25 pending · first 2019
Rank in peer group#2 of 42

Capital timeline

200820102012201420162018FEDERAL ↑EQUITY ↓Cumulative $4.2M$350K$750K$800K$1M$299K
200820102012201420162018FEDERAL ↑EQUITY ↓Cumulative $4.2M$350K$800K$1M

Latest events

  • Federal contractHealth and Human S · Rna Sequencing Kits$13K
  • Federal contractHealth and Human S · Igf::ot::igf - Bioo Scientific CORPORATION:1140473 [18-010784] - Invoice And Payment Provisions The Following Invoice And Payment Provisions Clause Is Applicable To All Purchase Orders, Task/delivery Orders And Bpa Calls: I. Invoice Requirements A. An Invoice Is The Vendor's Bill Or Written Request For Payment Under The Contract For Supplies Delivered Or Services Performed. A Proper Invoice Is An "original" Which Must Include The Items Listed In Bullets 1 Through 11 Below. If The Inv$9K
  • Federal contractHealth and Human S · Bio Scientific CORPORATION:1140473 [18-001489] Invoice And Payment Provisionsthe Following Invoice And Payment Provisions Clause Is Applicable To All Purchase Orders, Task/delivery Orders And Bpa Calls: I. Invoice Requirementsa. An Invoice Is The Vendor's Bill Or Written Request For Payment Under The Contract For Supplies Delivered Or Services Performed. A Proper Invoice Is An "original" Which Must Include The Items Listed In Bullets 1 Through 11 Below. If The Invoice Does Not Comply With $7K
  • Federal contractHealth and Human S · Igf::ot::igf - Bioo Scientific CORPORATION:1140473 [17-014610] Replacement For Req. 4733925INVOICE And Payment Provisionsthe Following Invoice And Payment Provisions Clause Is Applicable To All Purchase Orders, Task/delivery Orders And Bpa Calls: I. Invoice Requirementsa. An Invoice Is The Vendor's Bill Or Written Request For Payment Under The Contract For Supplies Delivered Or Services Performed. A Proper Invoice Is An "original" Which Must Include The Items Listed In Bullets 1 Through 11 $8K
  • Federal contractDefense · Nextflex Small Rna Sequencing Kit V3$21K
  • Federal contractAgriculture · Nigf::ot::igf Ext FLEX-96 Dna Barcodes$7K
  • Federal contractDefense · Igf::ot::igf$67K
Show 14 earlier federal awards
  • Federal grantHealth and Human S · Phase I · Sequencing of Epigenetic Modifications from Single Cells$299K
  • Federal grantHealth and Human S · Phase I · Digital Gene Expression Analysis by 3’ End Sequencing$270K
  • Federal grantDefense · Phase II · Burkholderia antibody molecules for therapeutics and diagnostics$1M
  • Federal contractDefense · Igf::ot::igf$800K
  • Federal grantNSF · Phase II · SBIR Phase II: High-throughput Small RNA Sequencing$750K
  • Federal contractHealth and Human S · Lab Supplies Dna Bar Code Kits$11K
  • Federal contractDefense · SBIR 2014.1 - Cbd Topic # 141-105$150K
  • Federal contractHealth and Human S · Igf::ct::igf FMD-81 Mdvp Histamine Project (biooscientific)$22K
  • Federal contractHealth and Human S · Laboratory Supplies$6K
  • Federal contractDefense · Bioo Scientific, SBIR Phase 1 10.3 Army, Erms # 11255005 Proposal # A112-106-0271$100K
  • Federal grantAgriculture · Sequential Injection Enzymatic Assay For Melamine Detection In Food.$80K
  • Federal grantAgriculture · Rapid Enzyme Based Detection Of Toxins In Food.$350K
  • Federal contractHealth and Human S · 402: Topic 229: Dev. Of Molecular Pharmacodynamic Assays For Tar Proposals Rec. PHS2008-1 Requestor: Andrew Kurtz Pop: 9/29/08 - 03/28/09$148K
  • Federal grantAgriculture · Rapid Enzyme-based Assays To Detect Banned Substances In Food$80K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 42 peers

Line = median

Biotech · Instrument

  • Federal grantsBelow median
  • Granted patents#2 · top 5%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 14 granted of 39
Show all 39 patent records

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .